These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25371202)

  • 21. Kinetic Characterization of Novel HIV-1 Entry Inhibitors: Discovery of a Relationship between Off-Rate and Potency.
    Meuser ME; Murphy MB; Rashad AA; Cocklin S
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30081466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions.
    Qi Q; Wang Q; Chen W; Du L; Dimitrov DS; Lu L; Jiang S
    Emerg Microbes Infect; 2017 Jun; 6(6):e59. PubMed ID: 28634358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism.
    Tuzer F; Madani N; Kamanna K; Zentner I; LaLonde J; Holmes A; Upton E; Rajagopal S; McFadden K; Contarino M; Sodroski J; Chaiken I
    Proteins; 2013 Feb; 81(2):271-90. PubMed ID: 23011758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.
    Jay JI; Lai BE; Myszka DG; Mahalingam A; Langheinrich K; Katz DF; Kiser PF
    Mol Pharm; 2010 Feb; 7(1):116-29. PubMed ID: 20014858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular Infectivity.
    Kalyana Sundaram RV; Li H; Bailey L; Rashad AA; Aneja R; Weiss K; Huynh J; Bastian AR; Papazoglou E; Abrams C; Wrenn S; Chaiken I
    Biochemistry; 2016 Jan; 55(3):447-58. PubMed ID: 26713837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators.
    Pustylnikov S; Dave RS; Khan ZK; Porkolab V; Rashad AA; Hutchinson M; Fieschi F; Chaiken I; Jain P
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):93-100. PubMed ID: 26383762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide Triazole Inhibitors of HIV-1: Hijackers of Env Metastability.
    P Carter E; G Ang C; M Chaiken I
    Curr Protein Pept Sci; 2023; 24(1):59-77. PubMed ID: 35692162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropism.
    Roche M; Jakobsen MR; Sterjovski J; Ellett A; Posta F; Lee B; Jubb B; Westby M; Lewin SR; Ramsland PA; Churchill MJ; Gorry PR
    J Virol; 2011 May; 85(9):4330-42. PubMed ID: 21345957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lytic Inactivation of Human Immunodeficiency Virus by Dual Engagement of gp120 and gp41 Domains in the Virus Env Protein Trimer.
    Parajuli B; Acharya K; Yu R; Ngo B; Rashad AA; Abrams CF; Chaiken IM
    Biochemistry; 2016 Nov; 55(44):6100-6114. PubMed ID: 27731975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.
    Roche M; Salimi H; Duncan R; Wilkinson BL; Chikere K; Moore MS; Webb NE; Zappi H; Sterjovski J; Flynn JK; Ellett A; Gray LR; Lee B; Jubb B; Westby M; Ramsland PA; Lewin SR; Payne RJ; Churchill MJ; Gorry PR
    Retrovirology; 2013 Apr; 10():43. PubMed ID: 23602046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike.
    Eggink D; de Taeye SW; Bontjer I; Klasse PJ; Langedijk JPM; Berkhout B; Sanders RW
    J Virol; 2016 Dec; 90(23):10587-10599. PubMed ID: 27654295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entry.
    Berinyuy E; Soliman ME
    J Recept Signal Transduct Res; 2016; 36(2):119-29. PubMed ID: 26446906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-acting stapled peptides target both HIV-1 entry and assembly.
    Zhang H; Curreli F; Waheed AA; Mercredi PY; Mehta M; Bhargava P; Scacalossi D; Tong X; Lee S; Cooper A; Summers MF; Freed EO; Debnath AK
    Retrovirology; 2013 Nov; 10():136. PubMed ID: 24237936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus-Cell Interface.
    Rashad AA; Song LR; Holmes AP; Acharya K; Zhang S; Wang ZL; Gary E; Xie X; Pirrone V; Kutzler MA; Long YQ; Chaiken I
    J Med Chem; 2018 Jun; 61(11):5020-5033. PubMed ID: 29767965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
    Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
    PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate.
    Wang X; Wang J; Zhang W; Li B; Zhu Y; Hu Q; Yang Y; Zhang X; Yan H; Zeng Y
    Viruses; 2018 May; 10(5):. PubMed ID: 29772712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
    Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
    Su S; Zhu Y; Ye S; Qi Q; Xia S; Ma Z; Yu F; Wang Q; Zhang R; Jiang S; Lu L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes.
    Aneja R; Grigoletto A; Nangarlia A; Rashad AA; Wrenn S; Jacobson JM; Pasut G; Chaiken I
    J Pept Sci; 2019 Apr; 25(4):e3155. PubMed ID: 30809901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate against HIV type 1 entry by targeting both viral envelope glycoprotein gp120 and cellular receptor CD4.
    Li M; Duan J; Qiu J; Yu F; Che X; Jiang S; Li L
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1455-64. PubMed ID: 23711095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.